These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10473854)

  • 21. Regional chemotherapy for colorectal hepatic metastases: evidence for improved survival with new drug combinations.
    Sutanto-Ward E; Arisawa Y; Tremiterra S; Sigurdson ER
    Ann Surg Oncol; 1996 Jan; 3(1):36-43. PubMed ID: 8770300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
    J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
    Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
    House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
    Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).
    Kusano M; Aoyama T; Okabayashi K; Hirata K; Tsuji Y; Nakamori S; Asahara T; Ohashi Y; Yoshikawa T; Sakamoto J; Oba K; Saji S
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S761-S766. PubMed ID: 30249900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional chemotherapy for liver-limited metastatic colorectal cancer.
    Power DG; Healey-Bird BR; Kemeny NE
    Clin Colorectal Cancer; 2008 Jul; 7(4):247-59. PubMed ID: 18650193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
    Bolton JS; O'Connell MJ; Mahoney MR; Farr GH; Fitch TR; Maples WJ; Nagorney DM; Rubin J; Fuloria J; Steen PD; Alberts SR
    Clin Colorectal Cancer; 2012 Mar; 11(1):31-7. PubMed ID: 21729678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
    J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer].
    Shitara K; Munakata M; Kudo T; Kasai M; Muto O; Okada R; Mitobe S; Ishiguro A; Sakuraba H; Ikami I; Sakata Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2033-7. PubMed ID: 17197748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer.
    Kelly RJ; Kemeny NE; Leonard GD
    Clin Colorectal Cancer; 2005 Sep; 5(3):166-74. PubMed ID: 16197619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases.
    Boilève A; De Cuyper A; Larive A; Mahjoubi L; Najdawi M; Tazdait M; Gelli M; Tselikas L; Smolenschi C; Malka D; Pignon JP; Ducreux M; Boige V
    Eur J Cancer; 2020 Oct; 138():89-98. PubMed ID: 32871526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Takanishi K; Matsumoto J; Minami T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
    Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
    J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas.
    Lorenz M; Mueller HH; Mattes E; Gassel HJ; Junginger T; Saeger HD; Schramm H; Staib-Sebler E; Vetter G; Heinrich S; Köhne CH;
    Ann Oncol; 2001 Mar; 12(3):321-5. PubMed ID: 11332142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.
    Allard MA; Sebagh M; Baillie G; Lemoine A; Dartigues P; Faitot F; Faron M; Boige V; Vitadello F; Vibert E; Elias D; Adam R; Goéré D; Sa Cunha A
    Ann Surg Oncol; 2015; 22(6):1925-32. PubMed ID: 25448804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasis.
    Volovat SR; Volovat C; Negru SM; Danciu M; Scripcariu V
    J Chemother; 2016 Jun; 28(3):235-41. PubMed ID: 26018108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?
    Mocellin S; Pilati P; Lise M; Nitti D
    J Clin Oncol; 2007 Dec; 25(35):5649-54. PubMed ID: 18065736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
    J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.